These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38893193)

  • 1. Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction Treatments.
    Westley R; Casey F; Mitchell A; Alexander S; Nill S; Murray J; Ratnakumaran R; Pathmanathan A; Oelfke U; Dunlop A; Tree AC
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
    Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
    Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion.
    De Bari B; Guibert G; Slimani S; Bashar Y; Risse T; Guisolan N; Trouillot J; Abel J; Weber P
    Curr Oncol; 2024 Feb; 31(2):962-974. PubMed ID: 38392066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy.
    Yoon S; Cao M; Aghdam N; Shabsovich D; Kahlon S; Ballas L; Collins S; Steinberg ML; Kishan AU
    Radiother Oncol; 2020 Jul; 148():44-50. PubMed ID: 32311600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
    Sengupta C; Skouboe S; Ravkilde T; Poulsen PR; Nguyen DT; Greer PB; Moodie T; Hardcastle N; Hayden AJ; Turner S; Siva S; Tai KH; Martin J; Booth JT; O'Brien R; Keall PJ
    Med Phys; 2023 Jan; 50(1):20-29. PubMed ID: 36354288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking.
    Jaccard M; Ehrbar S; Miralbell R; Hagen T; Koutsouvelis N; Poulsen P; Rouzaud M; Tanadini-Lang S; Tsoutsou P; Guckenberger M; Zilli T
    Radiother Oncol; 2021 Mar; 156():145-152. PubMed ID: 33310011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance image-guided adaptive radiotherapy enables safe CTV-to-PTV margin reduction in prostate cancer: a cine MRI motion study.
    Westley RL; Alexander SE; Goodwin E; Dunlop A; Nill S; Oelfke U; McNair HA; Tree AC
    Front Oncol; 2024; 14():1379596. PubMed ID: 38894866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
    Ma TM; Lamb JM; Casado M; Wang X; Basehart TV; Yang Y; Low D; Sheng K; Agazaryan N; Nickols NG; Cao M; Steinberg ML; Kishan AU
    BMC Cancer; 2021 May; 21(1):538. PubMed ID: 33975579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time.
    Ruggieri R; Rigo M; Naccarato S; Gurrera D; Figlia V; Mazzola R; Ricchetti F; Nicosia L; Giaj-Levra N; Cuccia F; Vitale C; Stavreva N; Pressyanov DS; Stavrev P; Pellegrini R; Alongi F
    Phys Med; 2020 Dec; 80():34-41. PubMed ID: 33091796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note.
    Jmour O; Benna M; Champagnol P; Ben Mrad M; Hamrouni A; Obeid L; Lahmamssi C; Bousarsar A; Vial N; Rehailia-Blanchard A; Sotton S; Lan M; Langrand-Escure J; Vallard A; Magné N
    Radiat Oncol; 2020 Apr; 15(1):85. PubMed ID: 32307017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT).
    Wolfe S; Diven MA; Marciscano AE; Zhou XK; Kishan AU; Steinberg ML; Miccio JA; Camilleri P; Nagar H
    BMC Cancer; 2023 Sep; 23(1):923. PubMed ID: 37777738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate radiotherapy treatment on a 1.5 Tesla MR-Linac: A practical method to mitigate intrafraction motion.
    Willigenburg T; Zachiu C; Bol GH; de Groot-van Beugel EN; Lagendijk JJW; van der Voort van Zyp JRN; Raaymakers BW; de Boer JCJ
    Radiother Oncol; 2022 Nov; 176():25-30. PubMed ID: 36113777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer.
    Mazzola R; Sicignano G; Cuccia F; Vitale C; Rigo M; Giaj-Levra N; Nicosia L; Figlia V; Ricchetti F; Attinà G; Pastorello E; De Simone A; Gurrera D; Naccarato S; Ruggieri R; Alongi F
    Br J Radiol; 2021 Oct; 94(1126):20210521. PubMed ID: 34283646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
    Waters M; Price A; Laugeman E; Henke L; Hugo G; Stowe H; Andruska N; Brenneman R; Hao Y; Green O; Robinson C; Gay H; Michalski J; Baumann BC
    Clin Transl Radiat Oncol; 2024 Jan; 44():100693. PubMed ID: 38021093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of intrafraction prostate motion on clinical target coverage in proton therapy: A simulation study of dosimetric differences in two delivery techniques.
    Su Z; Slopsema R; Flampouri S; Li Z
    J Appl Clin Med Phys; 2019 Oct; 20(10):67-73. PubMed ID: 31478341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1.5 T transverse magnetic field in radiotherapy of rectal cancer: Impact on the dose distribution.
    Uilkema S; van der Heide U; Sonke JJ; Moreau M; van Triest B; Nijkamp J
    Med Phys; 2015 Dec; 42(12):7182-9. PubMed ID: 26632072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
    Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
    Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
    Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
    J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.